Elo Mutual Pension Insurance’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
29,535
-71,331
-71% -$650K ﹤0.01% 590
2026
Q1
$909K Buy
100,866
+57,320
+132% +$905K 0.02% 497
2025
Q4
$794K Sell
43,546
-16,317
-27% -$275K 0.01% 536
2025
Q3
$878K Buy
59,863
+14,981
+33% +$257K 0.01% 534
2025
Q2
$817K Buy
44,882
+25,267
+129% +$515K 0.02% 494
2025
Q1
$389K Buy
+19,615
New +$339K 0.01% 591

Other funds holding ADMA

Elo Mutual Pension Insurance's ADMA Position: Q2 2026 in Review

Elo Mutual Pension Insurance reduced its ADMA Biologics (ADMA) stake by 71% in Q2 2026, selling an estimated $650K and leaving 29,535 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #590.

Elo Mutual Pension Insurance first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $909K in Q1 2026. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Elo Mutual Pension Insurance held 29,535 shares of ADMA Biologics worth $247K as of Q2 2026.
  • Elo Mutual Pension Insurance sold 71,331 ADMA Biologics shares in Q2 2026, an estimated $650K.
  • ADMA Biologics made up ﹤0.01% of Elo Mutual Pension Insurance's portfolio in Q2 2026, its #590 holding.
  • Elo Mutual Pension Insurance first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • Elo Mutual Pension Insurance's ADMA Biologics position peaked at $909K in Q1 2026.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Elo Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.